CIK 0000886744 · Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 752287752
- Phone
- 6504737700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-10 | Feller Faye EVP, Chief Medical Officer | Option exercise · Stock Option (right to buy) | −112,500 | 87,500 | ||
| 2024-06-10 | Feller Faye EVP, Chief Medical Officer | Option exercise · Stock Option (right to buy) | −20,000 | 0 | ||
| 2024-06-10 | Feller Faye EVP, Chief Medical Officer | Option exercise · Stock Option (right to buy) | −155,400 | 0 | ||
| 2024-06-10 | Kapur Anil EVP, Corp Strategy & CCO | Option exercise | +421,875 | $1.06 | $447K | 421,875 |
| 2024-06-10 | Kapur Anil EVP, Corp Strategy & CCO | Sale | −421,875 | $4.65 | $2.0M | 0 |
| 2024-06-10 | Kapur Anil EVP, Corp Strategy & CCO | Option exercise · Stock Option (right to buy) | −421,875 | 328,125 | ||
| 2024-06-06 | Kapur Anil EVP, Corp Strategy & CCO | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2024-06-06 | SCARLETT JOHN A Chairman, President and CEO | Grant or award · Employee Stock Option (right to buy) | +1,000,000 | 1,000,000 | ||
| 2024-06-06 | Samuels Scott Alan EVP, Chief Legal Officer | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2024-06-06 | ROBERTSON MICHELLE EVP, Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2024-06-06 | Feller Faye EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-06-06 | Feller Faye EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2024-06-06 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Grant or award · Employee Stock Option (right to buy) | +452,804 | 452,804 | ||
| 2024-06-04 | SCARLETT JOHN A Chairman, President and CEO | Option exercise | +600,000 | $2.54 | $1.5M | 600,000 |
| 2024-06-04 | SCARLETT JOHN A Chairman, President and CEO | Sale | −600,000 | $4.00 | $2.4M | 600,000 |
| 2024-06-04 | SCARLETT JOHN A Chairman, President and CEO | Option exercise · Stock Option (right to buy) | −600,000 | 0 | ||
| 2024-05-15 | LAWLIS V BRYAN Director | Option exercise 10b5-1 | +35,000 | $1.94 | $68K | 35,000 |
| 2024-05-15 | LAWLIS V BRYAN Director | Sale 10b5-1 | −35,000 | $3.75 | $131K | 0 |
| 2024-05-15 | LAWLIS V BRYAN Director | Option exercise · Stock Option (right to buy) 10b5-1 | −35,000 | 0 | ||
| 2024-05-09 | Aggarwal Gaurav Director | Grant or award · Stock Option (right to buy) | +180,000 | 180,000 |
Page 4 of 7 · 138 trades